Marwan Kwok
机构: CRUK Clinician Scientist, University of Birmingham & Dana-Farber Cancer Institute
每年引用次数
引用次数
引用: 1,619
H-指数: 12
I10-指数 : 12
出版物: 40
Targeting Replication Stress in Sporadic Tumours
Tatjana Stankovic , Marwan Cheng Kuang Kwok
CRC Press 329 -340
2018
Natural history and mechanism of spontaneous CLL regression: an integrative analysis of 20 cases
Marwan Cheng Kuang Kwok , Andy Rawstron , Anshita Goel , Grigorios Papatzikas
Taylor & Francis 225 -226
2020
Achieving minimal residual disease (MRD) negativity in CLL is independently associated with improved progression-free and overall survival and is an appropriate end-point of therapy
Marwan Cheng Kuang Kwok , Andy C Rawstron , Abraham Varghese , Peter Hillmen
20 -20
2010
Novel insights into the clinical heterogeneity and treatment of chronic lymphocytic leukaemia
Marwan Cheng Kuang Kwok
University of Birmingham
2018
Cancer and COVID-19: On the Quest for Effective Vaccines
Catherine J. Wu , Marwan Kwok , Marwan Kwok , Edward F. Fritsch
Blood Cancer Discovery 2 ( 1) 13 -18
2021
BCR Unresponsiveness and 13q14 Duplication Underpin Spontaneous Disease Regression in Chronic Lymphocytic Leukemia
Francesco Forconi , Andy Rawstron , Ceri Oldreive , Tatjana Stankovic
Blood 130 3004 -3004
2017
Minimal Residual Disease Is a Predictor for Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia (CLL) That Is Independent of the Type or Line of Therapy.
Marwan Kwok , Andy C. Rawstron , Abraham Varghese , Peter Hillmen
Blood 114 ( 22) 540 -540
18
2009
Monoclonal B-Cell Lymphocytosis (MBL) Is a Precursor State for Chronic Lymphocytic Leukemia (CLL) with 1% Progression Per Year.
Andrew S. Jack , Peter Hillmen , Andy C. Rawstron , Fiona L. Bennet
Blood 110 ( 11) 749 -749
1
2007
Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL
Marwan Kwok , Ceri Oldreive , Andy C. Rawstron , Anshita Goel
Blood 135 ( 6) 411 -428
4
2020
Minimal residual disease is an independent predictor for 10-year survival in CLL
Marwan Kwok , Andy C. Rawstron , Abraham Varghese , Paul A. S. Evans
Blood 128 ( 24) 2770 -2773
69
2016
USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status.
Angelo Agathanggelou , Edward Smith , Nicholas J. Davies , Marwan Kwok
Blood 130 ( 2) 156 -166
36
2017
Kinetics of CLL Subclonal Architecture: Spontaneous Disease Progression or Treatment-Induced Selection?
Ceri Oldreive , Nick Davies , Anna Skowronska , Marwan Kwok
Blood 126 ( 23) 167 -167
2015
Targeting the Ataxia Telangiectasia and Rad3 Signaling Pathway to Overcome Chemoresistance in Cancer
Marwan Kwok , Tatjana Stankovic
Academic Press 203 -230
2019
Synthetic Lethality In CLL With DNA Damage Response Defect By Targeting ATR Pathway
Tatjana Stankovic , Davies Nicholas , Marwan Kwok , Edward Smith
Blood 122 ( 21) 120 -120
2
2013
Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts
Nicholas J. Davies , Marwan Kwok , Clive Gould , Ceri E. Oldreive
Oncotarget 8 ( 27) 44749 -44760
6
2017
Genetics in the era of targeted CLL therapy.
Tatjana Stankovic , Marwan Kwok
Blood 135 ( 26) 2333 -2334
2020
ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells
Marwan Kwok , Nicholas Davies , Angelo Agathanggelou , Edward Smith
Blood 127 ( 5) 582 -595
122
2016
CLL Progression Is Associated with Increased Clonal Diversity and Replication Stress
Angelo Agathanggelou , Anna Skowronska , Nick Davies , Marwan Kwok
Blood 124 ( 21) 1977 -1977
2014
Independent prognostic significance of minimal residual disease status in chronic lymphocytic leukaemia
Marwan Kwok , Andy Rawstron , Abraham Varghese , Paul Evans
The Lancet 383 S66
3
2014
Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia.
Helen M. Parry , Nikhil Mirajkar , Natasha Cutmore , Jianmin Zuo
Frontiers in Immunology 10 2832
9
2019